Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Cynaroside
Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021
Amentoflavone
Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021
Zinc sulfate
Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/16/2021
C2 (IgG)
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/15/2021
D12 (IgG)
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/15/2021
Oroxylin A
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/15/2021
Quercetagetin 7-glucoside
Potential treatment - theoretical effect Natural product Antiviral Feb/15/2021
Echinacoside
Potential treatment - theoretical effect Natural product Antiviral Feb/15/2021
1,3-Dicaffeoylquinic acid
Potential treatment - theoretical effect Natural product Antiviral Feb/15/2021
Levan N
Potential treatment - theoretical effect Natural product Antiviral Feb/15/2021
Inulin
Potential treatment - theoretical effect Experimental Antiviral Feb/15/2021
NBP11
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
NBP10
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
ABP18
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
Hemin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/13/2021
COV2-2381
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
COV2-2072
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
COV2-3025
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
COV2-2050
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
Ferritin-NP-RBD
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/12/2021